As soon as he said this, everyone was in trouble. People are on the technical side, and Medtronic's heart stents are in great demand.

Patients with financial strength often choose imported stents. Acting as an agent for Medtronic's cardiac stents is also an important source of revenue for Nok Group.

Now the original factory asks for a price increase, and they have no bargaining strength, so they can only choose to accept it or not, because in addition to them, other agents also want to act as agents for this brand of heart stent.

"Send notices to hospitals and subordinate agents to increase the price by a certain amount. A vice president surnamed Wang said, "We have to ensure our profit margins." ”

"In doing so, we will definitely reduce our market share. Director Jia of the sales department did not agree, "Our cooperation with hospitals and subordinate agents is not only a heart stent, but also other medical devices. If we reduce our sales channels because of this, we may lose even more!"

"Well, the price remains the same. How about adjusting the product structure?" Song proposed the director of the product department, "Increase the sales share of self-produced cardiac stents and reduce the sales ratio of imported stents." ”

"In this way, it is okay, but I am afraid that the profit will drop a lot. The director of the production service department said helplessly, "The market competitiveness of our self-produced heart stent is not enough." ”

There are several types of cardiac stents, and the most commonly used ones are permanent stents made of metal materials. Such stents can introduce complications, such as foreign body inflammation, which can require the patient to take anticoagulants for the rest of their lives.

The imported cardiac stent, the multi-time drug-coated stent, is the metal stent after drug treatment, and the effect is better than the first one.

There are more advanced ones, which are bioresorbable stents. Cardiac stents made of soluble materials that are harmless to humans have the same effect as drug-coated stents, but they can dissolve on their own after the acute phase has passed, avoiding the adverse effects of local inflammation.

This bioresorbable stent technology is basically in the hands of foreign medical technology companies, and the domestic stents of the Nomada Group can only achieve the level of drug-coated stents at most.

"Reducing the proportion of inlet brackets is a must. Su Xueyan said, "At the same time, the price should also be adjusted." I have long emphasized that we can't keep being stuck in the throat of their masters!

Everyone was silent, thinking to themselves, it's easy to say, if it's so easy to mention, who will go to a foreign brand agent?

"I'm here to tell you one thing. Su Xueyan paused and said, "Last time I was invited to participate in the Huajin Industrial Science and Technology Exhibition, do you know?"

"Yes!" the crowd nodded.

"I had a big harvest on that trip! I found a domestic manufacturing company, and their manufacturing level is quite superb!" Su Xueyan continued, "I personally inspected it, and then sent colleagues from the R&D department to inspect it again. ”

"I decided to work with this company to develop a new technology, 3D printed heart stents. Attention, it's not a metal stent, it's a new generation of bioresorbable cardiac stents!"

"Yes, we have been preparing for this for a while!" said Zhu Jia, director of the R&D department.

There are also several high-level people here who know about this matter, but they don't care. After all, there are so many projects in the R&D department, and there are many projects that die in the middle of the process, but there are no finished products, which cannot be used as a quantitative reference for them.

"This company is called Z Time and Space, you can learn about it now. Su Xueyan asked the assistant to send the information to everyone.

"Z space-time? This company has been around for a short time. A vice president briefly glanced at it and said.

"Yes, it's not been around for a long time, but the technology is good. Su Xueyan said affirmatively.

"Mr. Su, I would like to ask, I see that the investment amount of this project has been increased, most of which is to be delivered to Z space, can they provide corresponding technical services?" asked a vice president and shareholder.

"I have this problem as well. I look at this information, Mr. Su, you plan to focus on 3D printing to manufacture heart stents. This project, it seems, does not have a great success rate. Director Song of the product department also raised doubts.

"At present, abroad, although there are precedents for this. But there are no projects that are officially put into production, and I doubt that we can do it."

"If you take too many steps, you will lose unnecessary money. ”

"Let me answer this point instead of Mr. Su. Zhu Jia from the R&D department said, "To be honest, when Mr. Su first told me about this, I was also strongly opposed. ”

"Later, I took the R&D personnel to Joaquin City to visit their factory and equipment. After experiencing their 3D printing technology, I think it's completely doable!"

"You're not in R&D, so you probably don't know. To make a cardiac stent, it is very important to make a cardiac stent, and the design of the material and structure is very important, and this is the difficulty. ”

That's why I agree with Mr. Su's point of view, this may be our opportunity, if the project is successful. In the future, we can make our own biosoluble heart stents and get rid of one of the technical pressures that Medtronic has pressed us!"

"Is this true?" the higher-ups were surprised, "and this kind of thing?"

"Director Zhu, I still can't believe that you say that!" Director Song of the product department continued, "If there is this kind of technology, why can't Medtronic make it, but a domestic 3D printer company can make it?"

"Besides, after so many years of research and development in the R&D department of our own group, is it just a company that makes printers in manufacturing?"

"It's not a printer, it's a 3D printer!" Su Xueyan emphasized, "I think you can also see more new technologies in the future, which is very helpful for our work and decision-making." ”

"Just three days ago, news came from Z time and space that they had built a 3D heart stent printer that could print soluble materials, and it would be sent to the company for experiments soon. ”

"How to make decisions about our cardiac stent sales strategy, let's put it after the experiment!"

The meeting ended, and Su Xueyan took the lead, but several other high-level executives were still discussing.

"3D printing? It's not realistic to use 3D printing technology to make cardiac stents!"

"The diameter of the cardiovascular system is only 2 to 5 millimeters, how difficult do you say it is to make a heart stent, or a soluble material with an uncontrollable structure? We haven't been able to get it out for so long, 3D printing will do?" he shook his head, saying he didn't believe it at all.